Morgan Stanley Iridex Corp Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Iridex Corp stock. As of the latest transaction made, Morgan Stanley holds 690 shares of IRIX stock, worth $1,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
690
Previous 690
-0.0%
Holding current value
$1,386
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IRIX
# of Institutions
34Shares Held
3.29MCall Options Held
4.8KPut Options Held
119K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$2.01 Million5.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$1.13 Million0.0% of portfolio
-
Amh Equity LTD456KShares$917,3631.4% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny410KShares$824,4210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA121KShares$242,5940.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $32.1M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...